Articles

Podcasts

Videos

Dr. Mulshine and Dr. Rizzo discuss the diagnostic evolution detailed in several studies in the previous decades, and how CT screening can be used to detect lung cancer early in patients.





James Mulshine, MD: Advancements in CT Screening for Lung Cancer

In recognition of Lung Cancer Awareness Month, this episode featuring Dr. James Mulshine at Rush University explains the ins and outs of the improved 2021 lung cancer screening guidelines.

Lung Cancer Screening: Trials, Tribulations & Triumphs with Dr. James Mulshine

Investigators also found a high prevalence between OSAS, nasal polyps, nutritional status, and other clinical variables.

High Rates of Sleep Apnea for Pediatric Cystic Fibrosis Patients

The treatment cannot be granted full approval due to ongoing litigation. 

FDA Grants Temporary Approval for Treprostinil Inhalation Powder for PAH

To date, dupilumab is the only medicine to show clinically meaningful phase 3 results in this patient population, with regulatory fillings planned for 2022.





Dupilumab Treatment for Eosinophilic Esophagitis Detailed in Phase 3 Data

The REVEAL Lite 2 risk assessment tool confirmed that treatment with the agonist improved risk profile and long-term outcomes of patients with pulmonary arterial hypertension.

Risk Assessment Tool Determines Efficacy of Selexipag in Patients with PAH

The indication makes 6 to 11-year-old children with eosinophilic biomarkers or corticosteroid dependency eligible for the biologic add-on therapy.

FDA Expands Dupilumab to Moderate to Severe Pediatric Asthma

Investigators propose oral treprostinil be considered when treating patients with pulmonary arterial hypertension.

Healthcare, Pharmacy Costs Lower for Oral Treprostinil Than Oral Selexipag

ILD is a very broad category of chronic lung conditions with considerable nuance.  Glassberg joins to discuss the roles of biomarkers, biopsies and drugs, as well as multidisciplinary clinics and stem cell therapy.

Interstitial Lung Disease: Scratching Beneath the Surface with Dr. Marilyn Glassberg

A higher proportion of newly diagnosed patients with PAH showed improved risk status after the initiation of the oral prostacyclin receptor agonist.

Newly Diagnosed PAH Patients Benefit from Selexipag Treatment

Asthma

The HCPLive asthma page is a comprehensive resource for clinical news and insights on asthmatic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for allergic and severe asthma, and more.

COPD

COPD condition center page, resources on the topics of medical news and expert insight into chronic obstructive pulmonary disease can be found. Content includes articles, interviews, videos, podcasts, and breaking news on COPD research, treatment, and drug development.

Deep Vein Thrombosis 

The HCPLive deep vein thrombosis page is a resource for medical news and expert insights on DVT. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for thrombotic disease, and more.

Infectious Disease condition center page is a comprehensive resource for clinical news and insights on respiratory health. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for asthma, COPD, interstitial lung disease, COVID-19, and more.

Pulmonology